Neuro-Adaptive Shunt Systems for Personalized Cardiovascular Care

The present inventive concept discloses a next-generation implantable shunt system that leverages advancements in artificial intelligence, micro-robotics, and bio-hybrid technologies to provide real-time, adaptive fluid flow management for cardiovascular disease treatment.

The original patent addressed the need for invasive adjustment systems for implantable medical devices. However, these systems have limitations in terms of their invasiveness, lack of real-time adaptability, and limited functionality. The new inventive concept solves these problems by introducing a neuro-adaptive shunt system that can predict optimal fluid flow rates, non-invasively reconfigure the shunt, and perform self-maintenance tasks.

The neuro-adaptive shunt system comprises a neural network-based control module that predicts optimal fluid flow rates based on real-time physiological data. This prediction is used to adjust the flowpath of the implanted shunt via a shape-memory actuation component. The system can be non-invasively reconfigured using electromagnetic signals, and a micro-robotic system can navigate through the shunt's flowpath to perform maintenance tasks. Additionally, the shunt system can be integrated with living tissue-engineered components that adapt to changing physiological conditions, and a cloud-based platform enables remote monitoring and adjustment of the shunt settings.

The new inventive concept's novelty lies in its integration of AI, micro-robotics, and bio-hybrid technologies to create a real-time, adaptive fluid flow management system. The inventive step is the introduction of a neuro-adaptive control module that predicts optimal fluid flow rates and adjusts the shunt's flowpath accordingly, enabling personalized cardiovascular care.

Alternative embodiments may include using different types of sensors or data sources for the neural network-based control module, varying the design of the micro-robotic system, or integrating the shunt system with other implantable devices. Variations may include using different materials or geometries for the shunt body or adapting the system for use in other medical applications.

The neuro-adaptive shunt system has significant commercial potential in the cardiovascular disease treatment market, with potential applications in hospitals, clinics, and remote healthcare settings. The system's ability to provide personalized, real-time fluid flow management could improve patient outcomes, reduce healthcare costs, and increase market share for manufacturers and healthcare providers.